Invivyd (IVVD) Reports Strong Q4 Growth, Advances COVID Antibody to Phase 3
Invivyd, Inc. (NASDAQ:IVVD) is one of the best penny stocks to buy in 2026. On January 8, Invivyd, Inc.
Invivyd Inc. (IVVD)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Perceptive Advisors Joseph Edelman | 21,785,166 | $53,809,360 | 0.96% | |
| 2. | Biotechnology Value Fund / BVF Inc Mark Lampert | 19,525,000 | $48,226,750 | 1.62% | |
| 3. | Maverick Capital Lee Ainslie | 18,970,913 | $46,858,155 | 0.5% | |
| 4. | RA Capital Management Peter Kolchinsky | 17,119,096 | $42,284,167 | 0.43% | |
| 5. | Point72 Asset Management Steve Cohen | 16,653,036 | $41,132,999 | -18% | 0.05% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.50 | 50,000 | $125,000.00 | 50,000 | 2025-11-19 | Filing | |
| $4.52 | 8,000 | $36,160.00 | 8,000 | 2022-09-01 | Filing | |
| $4.62 | 584,451 | $2,700,163.62 | 9,248,250 | 2022-08-19 | Filing | |
| $4.31 | 1,265,549 | $5,454,516.19 | 8,663,799 | 2022-08-18 | Filing | |
| $4.04 | 1,000,000 | $4,040,000.00 | 7,398,250 | 2022-08-17 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.58 | 19,392 | $30,596.70 | 114,487 | 2026-02-18 | Filing | |
| $1.54 | 18,189 | $28,003.78 | 133,879 | 2026-02-17 | Filing | |
| $1.58 | 20,964 | $33,077.00 | 107,717 | 2026-02-18 | Filing | |
| $1.54 | 19,663 | $30,273.15 | 128,681 | 2026-02-17 | Filing | |
| $1.58 | 20,964 | $33,077.00 | 107,717 | 2026-02-18 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 32,543,142 | $80,869,708 | 0.04% | |
| 2. | 10,703,977 | $26,438,823 | 0% | |
| 3. | 5,809,256 | $14,348,862 | 0.22% | |
| 4. | 5,637,593 | $13,924,855 | 0% | |
| 5. | 3,546,947 | $8,760,958 | 0% |
News See All
10 Best Penny Stocks to Buy for 2026
A rally in large-cap growth stocks was the catalyst behind US equities powering to record highs in 2025.
BTIG Initiates Invivyd (IVVD) Coverage, Cites VYD2311’s Superior Market Potential Over Pemgarda
Invivyd Inc. (NASDAQ:IVVD) is one of the best biotech penny stocks to buy according to analysts.
10 Best Biotech Penny Stocks to Buy According to Analysts
On December 24, Jared Holz of Mizuho joined 'Power Lunch' on CNBC to talk about how to play biotech moving into 2026.
Invivyd, Inc. (IVVD): Advancing RSV Antibody VBY329 Amid Analyst Downgrade
Invivyd Inc. (NASDAQ:IVVD) is one of the best multibagger penny stocks to buy right now.
14 Best Multibagger Penny Stocks to Buy Right Now
The Russell 2000 Index has hit fresh highs heading into 2026, signaling renewed interest in small companies.
Invivyd, Inc. (NASDAQ:IVVD) Q3 2025 Earnings Call Transcript
Operator: Good morning, everyone, and welcome to the Q3 2025 Invivyd Earnings Conference Call. [Operator Instructions] Please also note today's event is being recorded.
Invivyd, Inc. (IVVD) Secures FDA Path for COVID-19 Antibody Approval
Invivyd, Inc. (NASDAQ:IVVD) is a commercial-stage biopharmaceutical company focused on developing antibody-based therapies for serious viral infections, including COVID-19 and influenza.
15 Best Biotech Penny Stocks to Invest in Right Now
Jared Holz, the healthcare strategist for Mizuho, spoke on CNBC's "Closing Bell Overtime" in July on whether the biotech industry is ready for a breakthrough.
H.C. Wainwright Lowers Invivyd (IVVD) PT to $5 Amid Q1 2025 Revenue Shortfall
On Wednesday, H.C. Wainwright analyst Matthew Hedberg adjusted the price target on Invivyd Inc. (NASDAQ:IVVD) from $10 to $5, while maintaining a Buy rating.
Hedge Fund Resource Center Billionaire Hedge Funds
